LAB10x – an incubator to accelerate research commercialisation
Supported by industry experts and investors, LAB10x aims to accelerate the deployment of next generation digital therapeutics and data-driven drug discovery from clinical artificial intelligence research and digital health innovations
LAB10x provides a solution to a significant unmet need: helping to ensure ground-breaking digital innovations in healthcare can be realised faster and more effectively, thereby leading to more personalised healthcare, new disease insights, new diagnostics
LAB10x is a collaboration between Sensyne Health plc, Evotec SE, the University of Oxford, Oxford University Innovation Ltd and Oxford Sciences Innovation plc. Projects accepted into LAB10x benefit from Sensyne Health’s strength in clinical AI and regulated
software development and data analysis under its Quality Management System, and Evotec’s leading drug discovery and development expertise.
Further details can be found at the LAB10x website, and researchers interested to find out more can contact James Groves at Oxford University Innovation.